X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2023/02/08/2603614/0/en/Santhera-Concludes-Agreement-with-French-Authorities-on-Raxone-Reimbursement-and-Plans-to-Submit-a-Request-for-an-Early-Access-Program-for-Vamorolone.html
https://www.globenewswire.com/news-release/2021/06/23/2251433/0/en/Santhera-Announces-Phase-4-LEROS-Trial-with-Raxone-Met-Primary-Endpoint-in-Patients-with-Leber-s-Hereditary-Optic-Neuropathy.html
http://www.pharmatimes.com/news/chiesis_raxone_recommended_for_use_within_nhs_wales_1368441
https://awmsg.nhs.wales/medicines-appraisals-and-guidance/medicines-appraisals/idebenone-raxone/
https://www.globenewswire.com/news-release/2020/05/20/2036079/0/en/Santhera-Completes-Enrollment-of-Phase-3-SIDEROS-Study-with-Puldysa-Idebenone-in-Duchenne-Muscular-Dystrophy-DMD.html
http://www.pharmatimes.com/news/ema_validates_santheras_puldysa_maa_1292425
http://www.pharmatimes.com/news/santhera_submits_maa_to_ema_for_puldysa_1289253
https://www.in-pharmatechnologist.com/Article/2019/05/27/Chiesi-acquires-Raxone-therapy-from-Santhera
https://www.contractpharma.com/contents/view_breaking-news/2019-05-24/santhera-chiesi-group-enter-raxone-license-agreement/
http://www.pharmatimes.com/news/early_access_to_santheras_dmd_therapy_raxone_extended_in_the_uk_1241518
http://www.pharmatimes.com/news/santheras_raxone_fails_in_ms_trial_1225944
https://endpts.com/santheras-raxone-fails-nihs-ms-study-in-latest-setback-shares-plunge/
https://www.yorkshireeveningpost.co.uk/news/world-first-for-leeds-as-drug-is-prescribed-1-9035825
http://www.pharmafile.com/news/516385/santheras-raxone-rejected-europe-duchenne-muscular-dystrophy
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/01/news_detail_002888.jsp&mid=WC0b01ac058004d5c1
http://www.pharmatimes.com/news/dmd_patients_in_the_uk_win_early_access_to_santheras_raxone_1196558
http://www.pharmatimes.com/news/three_new_medicines_cleared_for_use_by_nhs_scotland_1192496
http://www.pharmatimes.com/news/eu_regulators_review_santheras_raxone_for_duchenne_1046626
http://www.prnewswire.com/news-releases/new-review-of-idebenone-as-a-novel-therapeutic-approach-for-duchenne-muscular-dystrophy-564979401.html
http://drugdelivery.pharmaceutical-business-review.com/news/santhera-pharmaceuticals-launches-raxone-in-germany-021015-4684278
http://www.bloomberg.com/news/articles/2015-04-14/santhera-may-market-muscular-dystrophy-drug-on-its-own-in-u-s-
Market Place
Share 
